H Jeffrey Wilkins - Net Worth and Insider Trading
H Jeffrey Wilkins Net Worth
The estimated net worth of H Jeffrey Wilkins is at least $133 dollars as of 2024-05-21. H Jeffrey Wilkins is the Chief Medical Officer of Avalo Therapeutics Inc and owns about 12 shares of Avalo Therapeutics Inc (AVTX) stock worth over $133. Details can be seen in H Jeffrey Wilkins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that H Jeffrey Wilkins has not made any transactions after 2021-12-10 and currently still holds the listed stock(s).
Transaction Summary of H Jeffrey Wilkins
H Jeffrey Wilkins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, H Jeffrey Wilkins owns 1 companies in total, including Avalo Therapeutics Inc (AVTX) .
Click here to see the complete history of H Jeffrey Wilkins’s form 4 insider trades.
Insider Ownership Summary of H Jeffrey Wilkins
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2021-12-10 | Chief Medical Officer |
H Jeffrey Wilkins Latest Holdings Summary
H Jeffrey Wilkins currently owns a total of 1 stock. H Jeffrey Wilkins owns 12 shares of Avalo Therapeutics Inc (AVTX) as of December 10, 2021, with a value of $133.
Latest Holdings of H Jeffrey Wilkins
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2021-12-10 | 12 | 11.10 | 133 |
Holding Weightings of H Jeffrey Wilkins
H Jeffrey Wilkins Form 4 Trading Tracker
According to the SEC Form 4 filings, H Jeffrey Wilkins has made a total of 2 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 2 shares on December 10, 2021, which cost H Jeffrey Wilkins around $10,003.
Insider Trading History of H Jeffrey Wilkins
- 1
H Jeffrey Wilkins Trading Performance
GuruFocus tracks the stock performance after each of H Jeffrey Wilkins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by H Jeffrey Wilkins is -42.82%. GuruFocus also compares H Jeffrey Wilkins's trading performance to market benchmark return within the same time period. The performance of stocks bought by H Jeffrey Wilkins within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how H Jeffrey Wilkins's insider trading performs compared to the benchmark.
Performance of H Jeffrey Wilkins
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.59 | | | | | |
| Relative Return to S&P 500(%) | -28.69 | | | | | |
H Jeffrey Wilkins Ownership Network
H Jeffrey Wilkins Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
H Jeffrey Wilkins is the Chief Medical Officer of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, H Jeffrey Wilkins made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 6,083 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
H Jeffrey Wilkins Mailing Address
Above is the net worth, insider trading, and ownership report for H Jeffrey Wilkins. You might contact H Jeffrey Wilkins via mailing address: 600 Lee Road, Suite 100, Wayne Pa 19087.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
